(28) There were no statistically significant differences in amputation risk between GLP-1s, SGLT-2 inhibitors, DPP4-Is, and all other agents
He said that the class of GLP-1ra appears to reduce cardiovascular events (in particular stroke), they are effective glucose lowering agents, help people lose weight and also reduce blood pressure
Similar content being viewed by others Background Metabolic syndrome is a complex metabolic disorder characterized by the manifestation of at least three concomitant clinical conditions among hypertension, obesity, hyperglycemia, hypertriglyceridemia, and hypercholesterolemia [1,2,3]
Healthcare professionals should approach disclosures of combined peptide use with a non-judgemental but clinically thorough assessment, and provide harm-minimisation advice where appropriate
20% off with code SUMMERSIZZLE Offer ends July 31, 2026